Michael J Hall
Overview
Explore the profile of Michael J Hall including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
182
Citations
4050
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Wilson-Shabazz I, Wheldon C, Hall M, Bauerle Bass S
J Psychosoc Oncol
. 2024 Sep;
:1-18.
PMID: 39258985
Background: Cancer providers are advised to inform their reproductive aged patients about fertility preservation given the potential for treatment-related infertility. How consistently fertility preservation discussions (FPDs) occur is understudied in...
12.
Ayon N, Earp C, Gupta R, Butun F, Clements A, Lee A, et al.
Metabolomics
. 2024 Aug;
20(5):90.
PMID: 39095664
Introduction: Fungi biosynthesize chemically diverse secondary metabolites with a wide range of biological activities. Natural product scientists have increasingly turned towards bioinformatics approaches, combining metabolomics and genomics to target secondary...
13.
Fonseca A, Coelho R, da-Silva M, Lemos L, Hall M, Oliveira D, et al.
Stem Cells Dev
. 2024 Jul;
33(19-20):528-539.
PMID: 39078329
Choroideremia (CHM) is a rare X-linked chorioretinal dystrophy causing progressive vision loss due to mutations in the gene, leading to Rab escort protein 1 loss of function. CHM disease is...
14.
Cheng H, Shevach J, Castro E, Couch F, Domchek S, Eeles R, et al.
JAMA Oncol
. 2024 Jul;
10(9):1272-1281.
PMID: 39052257
Importance: Half of all carriers of inherited cancer-predisposing variants in BRCA1 and BRCA2 are male, but the implications for their health are underrecognized compared to female individuals. Germline variants in...
15.
Rangel-Grimaldo M, Earp C, Raja H, Wood J, Mardiana L, Ho K, et al.
J Nat Prod
. 2024 Jul;
87(8):2095-2100.
PMID: 39039966
Wheldone is a fungal metabolite isolated from the coculture of and , displaying cytotoxic activity against breast, melanoma, and ovarian cancer cell lines. Initially, its structure was characterized as an...
16.
Shah S, Demidova E, Ringenbach S, Faezov B, Andrake M, Gandhi A, et al.
Cancer Res Commun
. 2024 May;
4(5):1398.
PMID: 38819318
No abstract available.
17.
Tung N, Ricker C, Messersmith H, Balmana J, Domchek S, Stoffel E, et al.
J Clin Oncol
. 2024 May;
42(21):2599-2615.
PMID: 38759122
Purpose: To guide use of multigene panels for germline genetic testing for patients with cancer. Methods: An ASCO Expert Panel convened to develop recommendations on the basis of a systematic...
18.
Ioffe D, McSweeny M, Hall M
Clin Colon Rectal Surg
. 2024 Apr;
37(3):157-171.
PMID: 38617845
The recognized importance of microsatellite instability (MSI) in cancer has evolved considerably in the past 30 years. From its beginnings as a molecular predictor for Lynch syndrome, MSI first transitioned...
19.
Hall M, DAvanzo P, Chertock Y, Kelly P, Brajuha J, Singley K, et al.
BMC Cancer
. 2024 Apr;
24(1):412.
PMID: 38566032
Background: Tumor genomic profiling (TGP) identifies targets for precision cancer treatments, but also secondary hereditary risks. Oncologists are poorly trained to communicate the results of TGP, especially among patients with...
20.
Muquith M, Espinoza M, Elliott A, Xiu J, Seeber A, El-Deiry W, et al.
Nat Cancer
. 2024 Mar;
5(7):1121-1129.
PMID: 38528112
Immune checkpoint inhibitors (ICIs) targeting programmed cell death protein 1 or its ligand (PD-1/L1) have expanded the treatment landscape against cancers but are effective in only a subset of patients....